Picard Medical Inc.

PMI | AMEX

Price Alert Chart Builder DCF Calculator

$8.35

+$0.24 (+2.96%)

At close: Oct 30, 2026, 4:00 PM ET

$8.29

-$0.06 (-0.72%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $857.51M

Enterprise Value $858.35M

Beta -2.64

Average Volume 1.31M

Shares Outstanding (Diluted) 1.86M

Shares Change YoY 5.17%

Institutional Ownership 8.20%

Exchange AMEX

ISIN US71953R2076

Price Performance

Price Change 1M 98.8%

Price Change 3M 89.8%

Price Change 6M -61.9%

Price Change YTD -90.5%

Price Change 1Y -93.9%

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 64.4%

1Y CAGR (ann.) -94.9%

5Y CAGR (ann.) N/A

All-Time CAGR -94.1%

Valuation

PE Ratio -0.41

Forward PE N/A

PEG Ratio 0.06

Forward PEG 0.01

PS Ratio 136.11

Forward PS 145.30

PB Ratio 499.72

P/FCF Ratio -53.36

P/Adj. FCF Ratio -47.52

P/OCF Ratio -0.97

EV/Sales 136.25

EV/EBIT -34.92

EV/EBITDA -35.68

EV/FCF -53.42

Earnings Yield -245.0%

FCF Yield -1.9%

Adj. FCF Yield -2.1%

Financial Health

Net Debt $840K

Total Debt $878K

Cash & Short-Term Investments $38K

Total Assets $9.17M

Current Ratio 1.02

Quick Ratio 0.22

Debt / Equity Ratio 0.51

Debt / EBITDA -0.04

Debt / FCF -0.05

OCF / Debt -18.27

Interest Coverage -6.07

Altman Z-Score 47.15

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 25.0%

Operating Profit Margin -240.8%

EBITDA Margin -381.8%

Net Profit Margin -444.3%

FCF Margin -255.1%

Adj. FCF Margin -286.4%

SBC / Revenue 31.4%

SBC Impact (per share) -12.3%

Returns

Return on Assets -305.4%

Return on Equity -931.1%

Return on Invested Capital -584.4%

Return on Capital Employed -884.2%

Return on Tangible Assets -346.1%

Historical Growth (CAGR)

Revenue CAGR 3Y 6.3%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -18.9%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -14.2%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 1

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 13, 2026

EPS Estimate (next Q) -$1.50

EPS Growth Est (next Q) 689.5%

Revenue Est (next Q) $1.55M

Revenue Growth Est (next Q) 30.6%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $0.00

Price Target Upside N/A

Cash Flow

Operating Cash Flow $-16.04M

Free Cash Flow $-16.07M

Adj. Free Cash Flow $-18.04M

FCF Per Share -$8.66

OCF Per Share -$8.64

OCF/S Ratio -254.7%

Income Statement

Revenue $6.3M

Gross Profit $1.58M

Operating Income $-15.17M

EBITDA $-24.06M

Net Income $-27.99M

EPS (Diluted) -$20.46

Revenue / Employee $84K

Profit / Employee $-373.21K

Employees 75